{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:12:19Z","timestamp":1760094739387,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.biopha.2006.12.005","type":"journal-article","created":{"date-parts":[[2007,1,2]],"date-time":"2007-01-02T13:50:55Z","timestamp":1167745855000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART"],"prefix":"10.1016","volume":"62","author":[{"given":"Dj.","family":"Jevtovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ranin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Salemovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Pe\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dragovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"\u017derjav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Djurkovi\u0107-Djakovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. A","key":"10.1016\/j.biopha.2006.12.005_bib1","first-page":"S25","article-title":"Immune reconstitution in HIV infection","volume":"13","author":"Gea-Banacloche","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib2","first-page":"51","article-title":"Immune reconstitution under highly active antiretroviral therapy (HAART)","volume":"1","author":"Carcelain","year":"1999","journal-title":"AIDS Rev"},{"key":"10.1016\/j.biopha.2006.12.005_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1468-1293.2004.00185.x","article-title":"Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy","volume":"5","author":"Duni\u0107","year":"2004","journal-title":"HIV Med"},{"key":"10.1016\/j.biopha.2006.12.005_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200401020-00001","article-title":"Care of patients with hepatitis C and HIV co-infection","volume":"18","author":"Soriano","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib5","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.biopha.2006.12.005_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.aids.0000163948.62176.e7","article-title":"Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel","volume":"19","author":"Soriano","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.aids.0000198091.70325.f4","article-title":"Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort","volume":"20","author":"Braitstein","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/00002030-199810000-00025","article-title":"Hepatotoxicity after introduction of highly active antiretroviral therapy","volume":"12","author":"Rodriquez-Rosado","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib9","doi-asserted-by":"crossref","first-page":"F115","DOI":"10.1097\/00002030-199912030-00002","article-title":"Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996\u20131998","volume":"13","author":"Saves","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2006.12.005_bib11","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection","volume":"14","author":"Den Brinker","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib12","first-page":"114","article-title":"Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART","volume":"28","author":"d'Arminio","year":"2001","journal-title":"JAIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib13","first-page":"426","article-title":"Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy","volume":"27","author":"Nunez","year":"2001","journal-title":"JAIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.20074","article-title":"Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine","volume":"39","author":"Walker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2006.12.005_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00002030-200107060-00007","article-title":"Hepatotoxicity in HIV-1 infected patients receiving\u00a0nevirapine-containing antiretroviral therapy","volume":"15","author":"Martinez","year":"2001","journal-title":"AIDS"},{"issue":"Suppl. 2","key":"10.1016\/j.biopha.2006.12.005_bib16","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1086\/381450","article-title":"Drug-induced liver injury associated with the use of non-nucleoside reverse-transcriptase inhibitors","volume":"38","author":"Dietrich","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biopha.2006.12.005_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jac\/dkl214","article-title":"Incidence ad risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C","volume":"58","author":"Mira","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.biopha.2006.12.005_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","article-title":"Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy","volume":"1","author":"French","year":"2000","journal-title":"HIV Med"},{"key":"10.1016\/j.biopha.2006.12.005_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2005.00277.x","article-title":"The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy","volume":"6","author":"Jevtovi\u0107","year":"2005","journal-title":"HIV Med"},{"issue":"RR-17","key":"10.1016\/j.biopha.2006.12.005_bib20","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"CDC","year":"1992","journal-title":"MMWR"},{"year":"1996","series-title":"Table of grading severity of adult adverse experiences","author":"AIDS Clinical Trials Group","key":"10.1016\/j.biopha.2006.12.005_bib21"},{"key":"10.1016\/j.biopha.2006.12.005_bib22","doi-asserted-by":"crossref","first-page":"N1","DOI":"10.1097\/01.aids.0000206497.93911.8c","article-title":"Hepatitis Cs effect on HIV disease remains elusive despite three new studies","volume":"20","author":"Crabb","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2006.12.005_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/432762","article-title":"Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy","volume":"192","author":"Rockstroh","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biopha.2006.12.005_bib24","first-page":"613","article-title":"Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy","volume":"39","author":"Backus","year":"2005","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.biopha.2006.12.005_bib25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1086\/432885","article-title":"Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events","volume":"41","author":"Stebbing","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332206003453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332206003453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:39:03Z","timestamp":1760092743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332206003453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0753332206003453"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2006.12.005","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2006.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}